A Randomized, Single-blind, Placebo-controlled, Sequential Parallel-Group and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-7072 in Healthy Subjects

Trial Profile

A Randomized, Single-blind, Placebo-controlled, Sequential Parallel-Group and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-7072 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs KBP 7072 (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions
  • Sponsors KBP Biosciences
  • Most Recent Events

    • 08 Oct 2017 Results assessing safety, tolerability and pharmacokinetics of KBP-7072, presented at the IDWeek 2017.
    • 13 May 2016 Status changed from recruiting to completed.
    • 28 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top